Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 156Lung Neoplasms 57Uterine Cervical Neoplasms 53Squamous Cell Carcinoma of Head and Neck 52Nasopharyngeal Carcinoma 51Head and Neck Neoplasms 47Stomach Neoplasms 37Parkinson Disease 4, Autosomal Dominant Lewy Body 35Esophageal Neoplasms 31Urinary Bladder Neoplasms 26Small Cell Lung Carcinoma 21Esophageal Squamous Cell Carcinoma 21Ovarian Neoplasms 19Carcinoma 14Neoplasm Metastasis 13Cholangiocarcinoma 13Recurrence 11Neuroblastoma 11Nasopharyngeal Neoplasms 11Carcinoma, Ovarian Epithelial 11Biliary Tract Neoplasms 11Adenocarcinoma Of Esophagus 11Neoplasms 10Gallbladder Neoplasms 10Carcinoma, Transitional Cell 10Testicular Neoplasms 9Adenocarcinoma of Lung 9Teratoma 8Oropharyngeal Neoplasms 8Endometrial Neoplasms 8

Interventions

Letrozole 5Paclitaxel 4atamestane 3Toremifene 3Tamoxifen 3Cyclophosphamide 3Estrogen Receptor Modulators 2Epirubicin 2Doxorubicin 2Docetaxel 2Carboplatin 2Capecitabine 2Aromatase Inhibitors 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2pertuzumab 1ferric carboxymaltose 1atezolizumab 1Vinorelbine 1Trastuzumab 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy 1Medroxyprogesterone 1Fulvestrant 1Fluorouracil 1Estrogens, Conjugated (USP) 1Cisplatin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Ductal, Breast × Cisplatin × Clear all
NCT02879513 2020-03-23

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

RenJi Hospital

Phase 3 Unknown
290 enrolled
Breast

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡